This content is machine translated More exercise, fewer transfusions Aspects of supportive therapy in oncology patients. At the annual congress of the German, Austrian and Swiss Societies of Hematology and Medical Oncology (DGHO) in Basel, various supportive measures were scrutinized during a symposium. More exercise during…
View Post 6 min This content is machine translated UEGW and Gastrointestinal Cancers Symposium Colorectal cancer – surgery and aftercare Should an asymptomatic colorectal primary tumor with nonresectable synchronous liver metastases be resected initially or only if there is a good response after chemotherapy? This question was discussed again at…
View Post 2 min This content is machine translated Non-small cell lung cancer Swiss approval of nivolumab As of November 30, 2015, nivolumab (Opdivo®) has been approved for locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy (regardless of histological subtype). This takes into…
View Post 8 min This content is machine translated Life goes on Desire for children after cancer therapy Rapid interdisciplinary consultation at the time of diagnosis of a malignancy is mandatory and enables “informed decision making” for those affected. Fertility protection should not worsen the prognosis. Failure to…
View Post 2 min This content is machine translated Meta-analysis on endometrial cancer Long-term protection through the use of oral contraceptives Oral contraceptives have prevented approximately half a million cases of endometrial cancer in industrialized nations over the past 50 years. This is the conclusion of a large-scale meta-analysis of 36…
View Post 7 min This content is machine translated 57th ASH Meeting in Orlando New field of application for rituximab The ASH Congress was held last year in Orlando. This time, one of the topics was the efficacy of rituximab in adult patients with B-precursor acute lymphoblastic leukemia (ALL). Up…
View Post 8 min This content is machine translated ESMO Asia 2015 News on gastric cancer, NET, head and neck tumors and NSCLC At the first ESMO congress in Asia (Singapore), the results of various large studies were discussed and classified in terms of their international significance. The aim of the conference was…
View Post 4 min This content is machine translated San Antonio Breast Cancer Symposium Modifications of neoadjuvant therapy New evaluations of the GeparSepto trial were presented at the San Antonio Breast Cancer Symposium. In this study, nab-paclitaxel is compared with solvent-containing paclitaxel as part of the neoadjuvant treatment…
View Post 9 min This content is machine translated New guidelines on plasma cell myeloma Contemporary clarification and therapy The treatment strategy is determined according to the patient’s age and general condition. Younger fit patients receive intensive treatment with induction therapy (at least four cycles), followed by high-dose chemotherapy/autologous…
View Post 2 min This content is machine translated Testicular cancer Switzerland is one of the countries with the highest incidence Testicular cancer is becoming increasingly common in industrialized nations. A study that examined development trends in the U.S. and Europe concludes that Switzerland in particular, along with Norway and Denmark,…
View Post 10 min This content is machine translated From high-dose chemotherapy to gene expression. Developments in adjuvant chemotherapy of breast carcinoma. The use of multigene testing is currently limited to the adjuvant setting in HER2-negative luminal breast carcinoma and allows reproducible predictions of recurrence risk. The tests will lead to fewer…
